Introduction : Tobacco treatment outcome methodology papers : a seriesHATSUKAMI, Dorothy K.Nicotine & tobacco research. 2001, Vol 3, Num 3, issn 1462-2203, p. 191Article

Tobacco treatment outcome methodology papers: a seriesHATSUKAMI, Dorothy K.Nicotine & tobacco research. 2002, Vol 4, Num 2, issn 1462-2203, p. 147Article

Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokersSOFUOGLU, Mehmet; BABB, David; HATSUKAMI, Dorothy K et al.Nicotine & tobacco research. 2003, Vol 5, Num 6, pp 947-953, issn 1462-2203, 7 p.Article

Progesterone treatment during the early follicular phase of the menstrual cycle : effects on smoking behavior in womenSOFUOGLU, Mehmet; BABB, David A; HATSUKAMI, Dorothy K et al.Pharmacology, biochemistry and behavior. 2001, Vol 69, Num 1-2, pp 299-304, issn 0091-3057Article

Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: a comparison of postmenopausal women using and not using hormone replacement therapyALLEN, Sharon S; HATSUKAMI, Dorothy K; CHRISTIANSON, Darcy et al.Nicotine & tobacco research. 2003, Vol 5, Num 1, pp 49-59, issn 1462-2203, 11 p.Article

Effects of progesterone treatment on smoked cocaine response in womenSOFUOGLU, Mehmet; BABB, David A; HATSUKAMI, Dorothy K et al.Pharmacology, biochemistry and behavior. 2002, Vol 72, Num 1-2, pp 431-435, issn 0091-3057, 5 p.Article

Individual differences in the subjective response to smoked cocaine in humansSOFUOGLU, Mehmet; BROWN, Scott; DUDISH-POULSEN, Susan et al.The American journal of drug and alcohol abuse. 2000, Vol 26, Num 4, pp 591-602, issn 0095-2990Article

Depressive symptoms modulate the subjective and physiological response to cocaine in humansSOFUOGLU, Mehmet; BROWN, Scott; BABB, David A et al.Drug and alcohol dependence. 2001, Vol 63, Num 2, pp 131-137, issn 0376-8716Article

Intravenous cocaine increases plasma epinephrine and norepinephrine in humansSOFUOGLU, Mehmet; NELSON, David; BABB, David A et al.Pharmacology, biochemistry and behavior. 2001, Vol 68, Num 3, pp 455-459, issn 0091-3057Article

Effect of nonnicotine pharmacotherapy on smoking behaviorKOTLYAR, Michael; GOLDING, Michael; HATSUKAMI, Dorothy K et al.Pharmacotherapy. 2001, Vol 21, Num 12, pp 1530-1548, issn 0277-0008Article

Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaineSOFUOGLU, Mehmet; DUDISH-POULSEN, Susan; BROWN, Scott B et al.Drug and alcohol dependence. 2003, Vol 69, Num 3, pp 273-282, issn 0376-8716, 10 p.Article

The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristicsLUBIN, Jay H; CAPORASO, Neil; HATSUKAMI, Dorothy K et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 9, pp 1852-1857, issn 1055-9965, 6 p.Article

Cigarette reduction : An intervention for adolescent smokersHANSON, Karen; ZYLLA, Emily; ALLEN, Sharon et al.Drug and alcohol dependence. 2008, Vol 95, Num 1-2, pp 164-168, issn 0376-8716, 5 p.Article

Efficacy of nicotine patch in Smokers with a history of alcoholismHUGHES, John R; NOVY, Pamela; HATSUKAMI, Dorothy K et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 6, pp 946-954, issn 0145-6008, 9 p.Article

Effects of cigarette reduction on cardiovascular risk factors and subjective measuresHATSUKAMI, Dorothy K; KOTLYAR, Michael; ALLEN, Sharon et al.Chest. 2005, Vol 128, Num 4, pp 2528-2537, issn 0012-3692, 10 p.Article

Clinical Trials Methods for Evaluation of Potential Reduced Exposure ProductsHATSUKAMI, Dorothy K; HANSON, Karen; BRIGGS, Anna et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 12, pp 3143-3195, issn 1055-9965, 53 p.Article

Toxicant exposure in cigarette reducers versus light smokersHATSUKAMI, Dorothy K; LE, Chap T; YING ZHANG et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 12, pp 2355-2358, issn 1055-9965, 4 p.Article

Reducing tobacco harm: Research challenges and issuesHATSUKAMI, Dorothy K; SLADE, John; BENOWITZ, Neal L et al.Nicotine & tobacco research. 2002, Vol 4, pp S89-S101, issn 1462-2203, SUP2Article

Test of measurement invariance of the FTND across demographic groups : Assessment, effect size, and prediction of cessationJOHNSON, Eric O; MORGAN-LOPEZ, Antonio A; BRESLAU, Naomi et al.Drug and alcohol dependence. 2008, Vol 93, Num 3, pp 260-270, issn 0376-8716, 11 p.Article

Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco useHECHT, Stephen S; CARMELLA, Steven G; MING YE et al.Cancer research (Baltimore). 2002, Vol 62, Num 1, pp 129-134, issn 0008-5472Article

Inhibition of CYP2D6 activity by bupropionKOTLYAR, Michael; BRAUER, Lisa H; TRACY, Timothy S et al.Journal of clinical psychopharmacology. 2005, Vol 25, Num 3, pp 226-229, issn 0271-0749, 4 p.Article

Safety and immunogenicity of a nicotine conjugate vaccine in current smokersHATSUKAMI, Dorothy K; RENNARD, Stephen; JORENBY, Douglas et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 5, pp 456-467, issn 0009-9236, 12 p.Article

Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettesHECHT, Stephen S; MURPHY, Sharon E; CARMELLA, Steven G et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 3, pp 693-698, issn 1055-9965, 6 p.Article

Ethylation and methylation of hemoglobin in smokers and non-smokersCARMELLA, Steven G; MENGLAN CHEN; VILLALTA, Peter W et al.Carcinogenesis (New York. Print). 2002, Vol 23, Num 11, pp 1903-1910, issn 0143-3334, 8 p.Article

CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco usersZHU, Andy Z. X; RENNER, Caroline C; HATSUKAMI, Dorothy K et al.Addiction (Abingdon. Print). 2013, Vol 108, Num 10, pp 1818-1828, issn 0965-2140, 11 p.Article